Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Quanterix CorporationNASDAQ: QTRX
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin widens to -48.2%
Net margin was -48.2% in Q1 FY2026, up 19.6 pp from a year earlier. On a trailing-twelve-month basis it was -71.9%, down 36.2 pp year over year. Over 3 fiscal years it widened by 17.1 pp.
Context
- Net margin widened in 1 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 2 analysts of -67.7% for the fiscal year ending Dec 2026, up from -77.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -48.2%+4.5 pp QoQ
- Last fiscal yearDec 2025
- -77.3%-48.8 pp YoY
- LTMMar 2026
- -71.9%-36.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +19.6 pp | +70.8 pp | +51.3 pp |
| 1 year | -48.8 pp | +9.5 pp | +58.4 pp |
| 3 years | +17.1 pp | +51.7 pp | +34.6 pp |
| 5 years | +65.4 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -77.3%
- Year-over-year change
- -48.8pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -77.3% | -48.8pp |
| FY2024 | 2024-12-31 | -28.4% | -5.0pp |
| FY2023 | 2023-12-31 | -23.4% | +71.0pp |
| FY2022 | 2022-12-31 | -94.4% | -44.1pp |
| FY2021 | 2021-12-31 | -50.2% | — |
Net Margin vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's LTM Mar 2026 net margin of -71.9% is the 7th highest of the 10 companies compared; the peer median is -62.1%.
- Its year-over-year change of -36.2 pp is the 9th highest of 10, against a peer median of +8.3 pp.
- Over three fiscal years its change of +17.1 pp compares with a peer median of +71.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 36.2% | +126.1 pp | +88.3 pp | |
| LTM Mar 2026 | 5.2% | -0.1 pp | +1.0 pp | |
| LTM Mar 2026 | -7.1% | +1.0 pp | +15.7 pp | |
| LTM Mar 2026 | -46.8% | +16.4 pp | +71.2 pp | |
| LTM Mar 2026 | -62.1% | -30.8 pp | +6.4 pp | |
| LTM Mar 2026 | -63.7% | +35.1 pp | +72.9 pp | |
| LTM Mar 2026 | -71.9% | -36.2 pp | +17.1 pp | |
| LTM Mar 2026 | -89.1% | +8.3 pp | +90.3 pp | |
| LTM Mar 2026 | -214.2% | +98.3 pp | -1063.2 pp | |
| LTM Dec 2025 | -576.1% | -101.8 pp | +650.8 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding QTRX) | -62.1% | +8.3 pp | +71.2 pp | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 110.56M | 105.52M | 121.14M | 135.44M | 138.65M |
| Cost of Revenue | 45.78M | 60.16M | 48.14M | 54.32M | 73.94M |
| Gross Profit | 64.77M | 45.36M | 73M | 81.12M | 64.72M |
| Gross Margin | 58.6% | 43.0% | 60.3% | 59.9% | 46.7% |
| Research & Development | 28.38M | 26.81M | 26.06M | 31.08M | 35.92M |
| Selling, General & Admin | 92.91M | 91.85M | 92.82M | 104.64M | 138.85M |
| Operating Expenses | 121.29M | 149.63M | 118.99M | 133.74M | 174.53M |
| Depreciation & Amortization | 4.88M | 5.41M | 8.29M | 8.36M | 18.93M |
| EBITDA | (50.3M) | (67.89M) | (36.37M) | (29.74M) | (93.35M) |
| EBITDA Margin | -45.5% | -64.3% | -30.0% | -22.0% | -67.3% |
| Operating Income | (56.52M) | (104.26M) | (45.99M) | (52.62M) | (109.82M) |
| Operating Margin | -51.1% | -98.8% | -38.0% | -38.8% | -79.2% |
| Interest Income | 0 | 5.13M | 15.84M | 14.66M | 8.57M |
| Interest Expense | 403K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 937K | 4.85M | 18.36M | 14.52M | (2.46M) |
| Income Before Tax | (55.58M) | (99.41M) | (27.64M) | (38.1M) | (112.27M) |
| Pre-Tax Margin | -50.3% | -94.2% | -22.8% | -28.1% | -81.0% |
| Income Tax Expense | (36K) | 164K | 719K | 434K | (5.12M) |
| Net Income | (55.55M) | (99.57M) | (28.35M) | (38.53M) | (107.15M) |
| Net Margin | -50.2% | -94.4% | -23.4% | -28.4% | -77.3% |
| EPS (Basic) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| EPS (Diluted) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| Weighted Avg Shares | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
| Weighted Avg Shares (Diluted) | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.